{"product_id":"biolegend-400126","title":"Biolegend, 400126, PE\/Cyanine7 Mouse IgG1, κ Isotype Ctrl Antibody, 100tests","description":"\u003cp\u003eThe MOPC-21 immunoglobulin has unknown specificity. The isotype of this antibody is mouse IgG1, κ. This antibody was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.\u003cbr\u003e\n100tests\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Mouse\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)\u003cbr\u003e\nPreparation: The antibody was purified by affinity chromatography, and conjugated with PE\/Cyanine7 under optimal conditions.\u003cbr\u003e\nConcentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)\u003cbr\u003e\nStorage \u0026amp; Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.\u003cbr\u003e\nApplication: FC - Quality tested ICFC - Verified\u003cbr\u003e\nRecommended Usage: Each lot of this mouse IgG1, κ isotype control antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, use the isotype control at the same concentration as your primary antibody.\u003cbr\u003e\nExcitation Laser: Blue Laser (488 nm)Green Laser (532 nm)\/Yellow-Green Laser (561 nm)\u003cbr\u003e\nApplication Notes: Additional reported applications (for the relevant formats) include: Intracellular Flow Cytometry (ICFC), Immunocytochemistry (ICC), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blotting (WB), Functional Assay (FA)\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Carlsten M, et al. 2007. Cancer Res. 67:1317. PubMed Smed-Sörensen A, et al. 2008. Blood 111:5037. PubMed (FA) Bunesmann MM, et al. 2011. Am. J. Respir. Cell. Mol. Biol. Epub. PubMed Matsuyama T, et al. 2005. Infect. Immun. 73:1044. (IF) Correia DV, et al. 2011. Blood 118:992. (FC) PubMed Lian IA, et al. 2011. Placenta. 32:823. PubMed Bufe B, et al. 20015. J Biol Chem. 290:7369. PubMed\u003cbr\u003e\nProduct Citations: Liisborg C, et al. 2022. Acta Ophthalmol. :3. PubMed Silva ATF, et al. 2022. Int J Mol Sci. 23:. PubMed Imai H, et al. 2023. iScience. 26:106822. PubMed Garcia-Larragoiti N, et al. 2021. J Thromb Haemost. 19:2572. PubMed Bhatt RS, et al. 2021. Cancer Immunol Res. 9:156. PubMed Lehmkuhl P, et al. 2021. Cell Mol Immunol. 18:1677. PubMed Diny NL, et al. 2022. J Exp Med. 219: . PubMed Connor T, et al. 2022. Methods Mol Biol. 2475:47. PubMed Cano-Mendez A, et al. 2022. Int J Mol Sci. 23: . PubMed Gerace D, et al. 2023. Cell Rep Med. 4:100879. PubMed Iancu O, et al. 2023. Mol Ther Nucleic Acids. 31:105. PubMed Vondra S, et al. 2023. Cell Rep. 42:111977. PubMed Eiza N, et al. 2023. Front Pharmacol. 13:1085892. PubMed Ulrich ND, et al. 2022. Dev Cell. 57:914. PubMed Lokmic Z, et al. 2015. J Vis Exp. 99: 52691. PubMed Chen X, et al. 2021. Theranostics. 11:4655. PubMed Kubo M, et al. 2018. Oncol Rep. 39:417. PubMed Love A, et al. 2015. J Leukoc Biol. 97:379. PubMed Zhou X, et al. 2013. PLoS One. 8:60332. PubMed Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed Liu R, et al. 2021. Commun Biol. 4:652. PubMed Iwabuchi R, et al. 2021. Frontiers in Immunology. 12:643040. PubMed Perelman SS, et al. 2021. Nat Microbiol. 6:731. PubMed Masuda T, et al. 2022. iScience. 25:104781. PubMed Liisborg C, et al. 2022. PLoS One. 17:e0269960. PubMed Murdock BJ, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed Helmink BA, et al. 2020. Nature. 577:549. PubMed Liang Y, et al. 2019. J Allergy Clin Immunol. 144:1025. PubMed Grandclaudon M, et al. 2019. Cell. 179:432. PubMed Jürchott K, et al. 2016. PLoS One. 11: 0150812. PubMed Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed Rhys HI, et al. 2018. EBioMedicine. 29:60. PubMed Luo Y, et al. 2021. Nat Commun. 12:3913. PubMed Sawasdee N, et al. 2022. Int J Mol Med. 49:. PubMed Hopf A, et al. 2022. Bioengineering (Basel). 9:. PubMed Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed Ko SY, et al. 2019. Commun Biol. 0.351388889. PubMed Liisborg C, et al. 2021. Aging (Albany NY). 13:25763. PubMed Kobayashi K, et al. 2016. Allergol Int. doi: 10.1016\/j.alit.2016.06.010. PubMed Mikulkova Z, et al. 2021. Sci Rep. 11:322. PubMed Howden S et al. 2019. Stem Cell Res. 1728:53:00 . PubMed Shaffer SM, et al. 2020. Cell. 182(4):947-959.e17. PubMed Zhou F, et al. 2018. Cancer Manag Res. 0.727083333. PubMed Hosseini Far H et al. 2019. Stem Cell Res. 1727:49:00 . PubMed Josowitz R, et al. 2016. Stem Cell Reports. 7: 355-369. PubMed Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed Katsuyama E, et al. 2020. Cell Reports. 30(1):112-123.e4.. PubMed Farhat AM, et al. 2021. Cell Reports. 35(4):109044. PubMed Bhushan S, et al. 2015. J Immunol. 194:5455. PubMed Luna-Yolba R, et al. 2021. Cancers (Basel). 13: . PubMed Headland S, et al. 2014. Sci Rep. 4:5237. PubMed Palpant N, et al. 2016. Nat Protoc. 12:15-31. PubMed Nagatake T, et al. 2019. Mucosal Immunol. 12:p1082. PubMed Parent AV, et al. 2021. Cell Reports. 36(7):109538. PubMed\u003cbr\u003e\nRRID: AB_2861433 (BioLegend Cat. No. 400125) AB_326448 (BioLegend Cat. No. 400126)\u003cbr\u003e\nGene ID: NA\u003cbr\u003e\nClone: MOPC-21\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nIsotype: Mouse IgG1, κ\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46866142888105,"sku":"400126","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/es\/products\/biolegend-400126","provider":"Iright","version":"1.0","type":"link"}